Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 95462-15-0
2. (+)-lycopsamine N-oxide
3. [(7r,8r)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3h-pyrrolizin-4-ium-1-yl]methyl (2s)-2-hydroxy-2-[(1s)-1-hydroxyethyl]-3-methylbutanoate
4. Lycopsamine N-oxide , Hplc Grade
5. Hy-n9512
6. Mfcd31697780
7. Nsc369514
8. Nsc-369514
9. Cs-0182699
Molecular Weight | 315.36 g/mol |
---|---|
Molecular Formula | C15H25NO6 |
XLogP3 | -1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 315.16818752 g/mol |
Monoisotopic Mass | 315.16818752 g/mol |
Topological Polar Surface Area | 105 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 479 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Lycopsamine N-Oxide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lycopsamine N-Oxide manufacturer or Lycopsamine N-Oxide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lycopsamine N-Oxide manufacturer or Lycopsamine N-Oxide supplier.
PharmaCompass also assists you with knowing the Lycopsamine N-Oxide API Price utilized in the formulation of products. Lycopsamine N-Oxide API Price is not always fixed or binding as the Lycopsamine N-Oxide Price is obtained through a variety of data sources. The Lycopsamine N-Oxide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Lycopsamine N-Oxide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lycopsamine N-Oxide, including repackagers and relabelers. The FDA regulates Lycopsamine N-Oxide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lycopsamine N-Oxide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lycopsamine N-Oxide supplier is an individual or a company that provides Lycopsamine N-Oxide active pharmaceutical ingredient (API) or Lycopsamine N-Oxide finished formulations upon request. The Lycopsamine N-Oxide suppliers may include Lycopsamine N-Oxide API manufacturers, exporters, distributors and traders.
Lycopsamine N-Oxide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lycopsamine N-Oxide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lycopsamine N-Oxide GMP manufacturer or Lycopsamine N-Oxide GMP API supplier for your needs.
A Lycopsamine N-Oxide CoA (Certificate of Analysis) is a formal document that attests to Lycopsamine N-Oxide's compliance with Lycopsamine N-Oxide specifications and serves as a tool for batch-level quality control.
Lycopsamine N-Oxide CoA mostly includes findings from lab analyses of a specific batch. For each Lycopsamine N-Oxide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lycopsamine N-Oxide may be tested according to a variety of international standards, such as European Pharmacopoeia (Lycopsamine N-Oxide EP), Lycopsamine N-Oxide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lycopsamine N-Oxide USP).